Published in Front Cell Neurosci on March 31, 2016
Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry (2005) 45.33
The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA (2003) 34.83
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science (2003) 28.61
Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature (2005) 18.41
hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell (2001) 15.97
From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci (2008) 15.90
Memory--a century of consolidation. Science (2000) 12.95
Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science (2004) 11.39
Caloric restriction delays disease onset and mortality in rhesus monkeys. Science (2009) 9.84
Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci U S A (2003) 9.14
Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry (2009) 8.74
Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol (2005) 8.49
Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiatry (2010) 8.02
Sirtuins in mammals: insights into their biological function. Biochem J (2007) 7.60
A meta-analysis of cytokines in major depression. Biol Psychiatry (2009) 7.16
The serotonin transporter promoter variant (5-HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Arch Gen Psychiatry (2011) 6.66
Nutrient-sensitive mitochondrial NAD+ levels dictate cell survival. Cell (2007) 6.47
Synaptic plasticity and addiction. Nat Rev Neurosci (2007) 6.08
The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis. Diabet Med (2006) 5.51
SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell (2010) 5.40
The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide-dependent deacetylase. J Cell Biol (2002) 5.37
SIRT1 transgenic mice show phenotypes resembling calorie restriction. Aging Cell (2007) 5.30
SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J (2007) 4.66
Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology (2007) 4.38
Nampt/PBEF/Visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme. Cell Metab (2007) 4.16
New insights into BDNF function in depression and anxiety. Nat Neurosci (2007) 3.94
Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. Proc Natl Acad Sci U S A (2004) 3.93
Anatomical and physiological plasticity of dendritic spines. Annu Rev Neurosci (2007) 3.75
Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies. Diabetes Care (2012) 3.53
Sirtuins as potential targets for metabolic syndrome. Nature (2006) 3.38
Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases myocardial triglyceride content and improves myocardial function. J Am Coll Cardiol (2008) 3.32
The brain reward circuitry in mood disorders. Nat Rev Neurosci (2013) 3.08
Development of lifetime comorbidity in the World Health Organization world mental health surveys. Arch Gen Psychiatry (2011) 3.01
Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Mol Psychiatry (2007) 2.66
Measuring the global burden of disease and epidemiological transitions: 2002-2030. Ann Trop Med Parasitol (2006) 2.53
The biochemistry of affective disorders. Br J Psychiatry (1967) 2.31
Silent information regulator 1 protects the heart from ischemia/reperfusion. Circulation (2010) 2.19
The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis. Neuropsychopharmacology (2011) 2.15
The critical role of metabolic pathways in aging. Diabetes (2012) 2.12
Caloric restriction attenuates Abeta-deposition in Alzheimer transgenic models. Neurobiol Aging (2004) 1.97
The prevalence of co-morbid depression in adults with Type 1 diabetes: systematic literature review. Diabet Med (2006) 1.96
Acute stress enhances glutamatergic transmission in prefrontal cortex and facilitates working memory. Proc Natl Acad Sci U S A (2009) 1.95
Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease. J Neurosci Res (1999) 1.94
Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nucl Med Biol (2007) 1.87
SIRT6 deficiency results in severe hypoglycemia by enhancing both basal and insulin-stimulated glucose uptake in mice. J Biol Chem (2010) 1.86
SIRT1 activates MAO-A in the brain to mediate anxiety and exploratory drive. Cell (2011) 1.86
GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression. Neuropsychopharmacology (2006) 1.80
Does depression cause obesity?: A meta-analysis of longitudinal studies of depression and weight control. J Health Psychol (2008) 1.80
SIRT1 promotes DNA repair activity and deacetylation of Ku70. Exp Mol Med (2007) 1.77
Sirt1 enhances skeletal muscle insulin sensitivity in mice during caloric restriction. J Clin Invest (2011) 1.74
SIRT1 is essential for normal cognitive function and synaptic plasticity. J Neurosci (2010) 1.71
Serotonin, genetic variability, behaviour, and psychiatric disorders--a review. Ups J Med Sci (2010) 1.67
Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J Affect Disord (2011) 1.58
Relationship of neurotransmitters to the symptoms of major depressive disorder. J Clin Psychiatry (2008) 1.56
Corticosteroid-serotonin interactions in the neurobiological mechanisms of stress-related disorders. Neurosci Biobehav Rev (2008) 1.50
Resting-state brain functional connectivity is altered in type 2 diabetes. Diabetes (2012) 1.49
Immune suppression and immune activation in depression. Brain Behav Immun (2010) 1.48
Regulation of neurogenesis and gliogenesis by stress and antidepressant treatment. CNS Neurol Disord Drug Targets (2007) 1.47
Should Depressive Syndromes Be Reclassified as "Metabolic Syndrome Type II"? Ann Clin Psychiatry (2007) 1.46
Depression as a risk factor for diabetes: a meta-analysis of longitudinal studies. J Clin Psychiatry (2013) 1.45
Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635. Mol Psychiatry (2004) 1.45
The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog Neuropsychopharmacol Biol Psychiatry (2010) 1.44
Depression: the case for a monoamine deficiency. J Clin Psychiatry (2000) 1.44
Cognitive mechanisms of treatment in depression. Neuropsychopharmacology (2011) 1.43
Sirtuins at a glance. J Cell Sci (2011) 1.41
Overview of the genetics of major depressive disorder. Curr Psychiatry Rep (2010) 1.39
Neurocognitive deficits and disability in major depressive disorder. Psychiatry Res (2006) 1.39
Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response. Mol Psychiatry (2008) 1.38
Cognitive dysfunction in depression: neurocircuitry and new therapeutic strategies. Neurobiol Learn Mem (2011) 1.37
Functional dissection of SIRT6: identification of domains that regulate histone deacetylase activity and chromatin localization. Mech Ageing Dev (2010) 1.30
SIRT1 and SIRT2: emerging targets in neurodegeneration. EMBO Mol Med (2013) 1.30
Microstructural white matter abnormalities and cognitive functioning in type 2 diabetes: a diffusion tensor imaging study. Diabetes Care (2012) 1.22
Decreased prefrontal Myo-inositol in major depressive disorder. Biol Psychiatry (2005) 1.22
Evaluation of in vivo cerebral metabolism on proton magnetic resonance spectroscopy in patients with impaired glucose tolerance and type 2 diabetes mellitus. J Diabetes Complications (2008) 1.20
High glucose induced alteration of SIRTs in endothelial cells causes rapid aging in a p300 and FOXO regulated pathway. PLoS One (2013) 1.20
Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects. Int J Neuropsychopharmacol (2012) 1.19
A review of the association between depression and insulin resistance: pitfalls of secondary analyses or a promising new approach to prevention of type 2 diabetes? Curr Psychiatry Rep (2012) 1.19
Pathways for ischemic cytoprotection: role of sirtuins in caloric restriction, resveratrol, and ischemic preconditioning. J Cereb Blood Flow Metab (2011) 1.18
Cognitive dysfunction in unipolar depression: implications for treatment. J Affect Disord (2013) 1.18
Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study. Psychol Med (2010) 1.16
Sirt1 overexpression in neurons promotes neurite outgrowth and cell survival through inhibition of the mTOR signaling. J Neurosci Res (2011) 1.16
Changes in brain MicroRNAs contribute to cholinergic stress reactions. J Mol Neurosci (2009) 1.16
Dopamine, depression and antidepressants. Fundam Clin Pharmacol (2004) 1.15
White matter microstructural integrity in youth with type 1 diabetes. Diabetes (2012) 1.15
Resting-state brain networks in type 1 diabetic patients with and without microangiopathy and their relation to cognitive functions and disease variables. Diabetes (2012) 1.13
Altered sirtuin deacetylase gene expression in patients with a mood disorder. J Psychiatr Res (2011) 1.11
Antidepressants inhibit interferon-gamma-induced microglial production of IL-6 and nitric oxide. Exp Neurol (2007) 1.11
Rho family GTPases as key regulators for neuronal network formation. J Biochem (2002) 1.11
Reduced density of calbindin immunoreactive GABAergic neurons in the occipital cortex in major depression: relevance to neuroimaging studies. Biol Psychiatry (2009) 1.10
Silent information regulator 1 protects the brain against cerebral ischemic damage. Stroke (2013) 1.09
Risk of future depression in people who are obese but metabolically healthy: the English longitudinal study of ageing. Mol Psychiatry (2012) 1.08
Microglia in the developing brain: a potential target with lifetime effects. Neurotoxicology (2012) 1.07
Alterations of cerebral metabolism in patients with diabetes mellitus studied by proton magnetic resonance spectroscopy. Exp Clin Endocrinol Diabetes (2003) 1.06
Resveratrol prevents antibody-induced apoptotic death of retinal cells through upregulation of Sirt1 and Ku70. BMC Res Notes (2008) 1.02
SIRT3 protects cardiomyocytes from oxidative stress-mediated cell death by activating NF-κB. Biochem Biophys Res Commun (2012) 1.00
The NAD-dependent deacetylase sirtuin 2 is a suppressor of microglial activation and brain inflammation. EMBO J (2013) 0.99
5-HT1 receptors. Curr Drug Targets CNS Neurol Disord (2004) 0.99
Effects of cytokines on glucocorticoid receptor expression and function. Glucocorticoid resistance and relevance to depression. Adv Exp Med Biol (1999) 0.97
Effects of chronic calorie restriction or dietary resveratrol supplementation on insulin sensitivity markers in a primate, Microcebus murinus. PLoS One (2012) 0.97
A neurobiological approach to the cognitive deficits of psychiatric disorders. Dialogues Clin Neurosci (2013) 0.97
Degeneration of Dopaminergic Neurons Due to Metabolic Alterations and Parkinson's Disease. Front Aging Neurosci (2016) 0.79